myelodysplastic syndromes (MDS) | Page 9 | Aplastic Anemia & MDS International Foundation

myelodysplastic syndromes (MDS)

Relationship between lenalidomide dose modification, duration of therapy, and long-term outcomes in patients with myelodysplastic syndromes

Author(s): 
DeZern AE, Binder G, Ni Q, McGuire M, Smith BD
Primary Author: 
DeZern AE
Journal Title: 
Leuk Res
Original Publication Date: 
Oct 2017

Dose reductions or interruptions may be required to manage treatment-associated adverse events among patients with

Bone Marrow Diseases: 

Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway

Author(s): 
Balaian E, Wobus M, Weidner H, Baschant U, Stiehler M, Ehninger G, Bornhäuser M, Hofbauer LC, Rauner M, Platzbecker U
Primary Author: 
Balaian E
Journal Title: 
Haematologica
Original Publication Date: 
Oct 2017

The effects of

Bone Marrow Diseases: 

Orlando

Thank you for attending the 2017 Patient and Family Conference in Orlando, FL.

Thank you for attending the 2017 Patient and Family Conference in Orlando, FL.
Event Date: 
Sat, 11/04/2017 -
8:00am to 3:30pm
Conference Event Type: 

Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors

Author(s): 
Mies A, Platzbecker U
Primary Author: 
Mies A
Journal Title: 
Semin Hematol
Original Publication Date: 
Jul 2017

Patients with lower-risk

Bone Marrow Diseases: 

Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity

Author(s): 
Madanat Y, Sekeres MA
Primary Author: 
Madanat Y
Journal Title: 
Semin Hematol
Original Publication Date: 
Jun 2017

Bone Marrow Diseases: 

Pro-inflammatory proteins S100A9 and TNFα suppress erythropoietin elaboration in myelodysplastic syndromes

Author(s): 
Cluzeau T, McGraw KL, Irvine B, Masala E, Ades L, Basiorka AA, Maciejewski JP, Auberger P, Wei S, Fenaux P, Santini V, List A
Primary Author: 
Cluzeau T
Journal Title: 
Haematologica
Original Publication Date: 
Oct 2017

Accumulating evidence implicates innate immune activation in the pathobiology of

Bone Marrow Diseases: 

Confronting Challenges in Finding Matches for Multiracial Patients

Person's Name: 
Krissy Kobata

34-year-old Krissy Kobata is a passionate patient and advocate/activist. Diagnosed in 2008 with MDS, she’s the epitome of resilience as she has waited for years to find a matched donor. She has devoted this time to helping other patients by enlarging the Be The Match® bone marrow registry.

Bone Marrow Diseases: